PL3325080T3 - Sposoby lepszego dostarczania środków czynnych do guzów - Google Patents

Sposoby lepszego dostarczania środków czynnych do guzów

Info

Publication number
PL3325080T3
PL3325080T3 PL16831139T PL16831139T PL3325080T3 PL 3325080 T3 PL3325080 T3 PL 3325080T3 PL 16831139 T PL16831139 T PL 16831139T PL 16831139 T PL16831139 T PL 16831139T PL 3325080 T3 PL3325080 T3 PL 3325080T3
Authority
PL
Poland
Prior art keywords
tumors
methods
active agents
better delivery
delivery
Prior art date
Application number
PL16831139T
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics, Inc. filed Critical Sorrento Therapeutics, Inc.
Publication of PL3325080T3 publication Critical patent/PL3325080T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023Drug applicators using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL16831139T 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów PL3325080T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562196578P 2015-07-24 2015-07-24
US201562196570P 2015-07-24 2015-07-24
EP16831139.7A EP3325080B1 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
PL3325080T3 true PL3325080T3 (pl) 2022-01-24

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16831139T PL3325080T3 (pl) 2015-07-24 2016-07-22 Sposoby lepszego dostarczania środków czynnych do guzów

Country Status (15)

Country Link
US (2) US10806913B2 (pl)
EP (2) EP3925599A1 (pl)
JP (1) JP7082041B2 (pl)
KR (1) KR20180035209A (pl)
CN (1) CN107921248A (pl)
AU (3) AU2016297823B2 (pl)
BR (1) BR112018001292A2 (pl)
CA (1) CA2991455C (pl)
DK (1) DK3325080T3 (pl)
ES (1) ES2891523T3 (pl)
HU (1) HUE056410T2 (pl)
MX (2) MX2018000166A (pl)
PL (1) PL3325080T3 (pl)
RU (1) RU2719943C2 (pl)
WO (1) WO2017019526A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych
AU2018269544B2 (en) * 2017-05-17 2024-06-13 Massachusetts Institute Of Technology Self-righting articles
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
EP3652133A4 (en) 2017-07-10 2021-04-21 Basf Se MIXTURES INCLUDING A UREASE INHIBITOR (IU) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG)
US11202903B2 (en) 2018-05-17 2021-12-21 Massachusetts Institute Of Technology Systems for electrical stimulation
CN112512502A (zh) * 2018-05-31 2021-03-16 索伦托药业有限公司 靶向淋巴系统的药物输送方法
EP3856321A1 (en) * 2018-09-24 2021-08-04 L'oreal Device comprising microneedles for skin-coloring
JP2023505231A (ja) 2019-12-05 2023-02-08 ソレント・セラピューティクス・インコーポレイテッド リンパ管送達デバイスによる抗pd-1または抗pd-l1治療剤の投与による癌の処置方法
EP4281167A1 (en) 2021-01-22 2023-11-29 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
AU2022290563A1 (en) 2021-06-09 2024-01-25 Vivasor, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
CA3228858A1 (en) 2021-08-18 2023-02-23 Russell F. Ross Therapeutic agents targeting the lymphatic system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
KR100795870B1 (ko) * 2000-06-01 2008-01-21 왓슨 파머수티컬즈, 인코포레이티드 라소폭시펜의 경피적 송달
MXPA04002283A (es) * 2001-09-12 2004-06-29 Becton Dickinson Co Dispositivo de pluma a base de microaguja para el suministro de farmaco y metodo para utilizar el mismo.
BRPI0411428A (pt) * 2003-06-13 2006-07-25 Becton Dickinson Co distribuição intradérmica de agentes biologicamente ativos
US20050180952A1 (en) 2003-08-26 2005-08-18 Pettis Ronald J. Methods for intradermal delivery of therapeutics agents
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
WO2006127962A2 (en) * 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
EP1893130A4 (en) * 2005-06-17 2015-08-26 Georgia Tech Res Inst COATED MICROSTRUCTURES AND METHOD FOR THE PRODUCTION THEREOF
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
WO2011135533A2 (en) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. Nanopatterned medical device with enhanced cellular interaction
US9586044B2 (en) 2010-04-28 2017-03-07 Kimberly-Clark Worldwide, Inc. Method for increasing the permeability of an epithelial barrier
US9522263B2 (en) 2010-04-28 2016-12-20 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
CN102985131B (zh) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 用于递送siRNA的医疗装置
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
AU2012326203B2 (en) 2011-10-17 2017-11-30 Massachusetts Institute Of Technology Intracellular delivery
US9550053B2 (en) 2011-10-27 2017-01-24 Kimberly-Clark Worldwide, Inc. Transdermal delivery of high viscosity bioactive agents
KR101575039B1 (ko) * 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
WO2014041531A1 (en) * 2012-09-13 2014-03-20 Amir Avraham Delivery devices and methods for skin augmentation
WO2014046983A1 (en) 2012-09-21 2014-03-27 Intensity Therapeutic Method of treating cancer
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
EP2961469A4 (en) 2013-02-28 2016-10-26 Kimberly Clark Co DEVICE FOR DELIVERY OF MEDICAMENT
KR102295456B1 (ko) 2013-02-28 2021-08-27 소렌토 쎄라퓨틱스, 인코포레이티드 경피 약물 전달 장치
BR112015027608A2 (pt) 2013-05-23 2017-07-25 Kimberly Clark Co microagulhas com geometrias transversais de canal aberto melhoradas
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors

Also Published As

Publication number Publication date
JP7082041B2 (ja) 2022-06-07
AU2021200146B2 (en) 2022-08-25
EP3925599A1 (en) 2021-12-22
EP3325080A2 (en) 2018-05-30
RU2719943C2 (ru) 2020-04-23
EP3325080A4 (en) 2019-04-17
US20210052871A1 (en) 2021-02-25
CA2991455C (en) 2023-10-10
CA2991455A1 (en) 2017-02-02
BR112018001292A2 (pt) 2018-09-11
US20180193624A1 (en) 2018-07-12
CN107921248A (zh) 2018-04-17
DK3325080T3 (da) 2021-10-04
JP2018521755A (ja) 2018-08-09
US10806913B2 (en) 2020-10-20
WO2017019526A2 (en) 2017-02-02
AU2016297823B2 (en) 2020-10-22
MX2018000166A (es) 2018-03-26
KR20180035209A (ko) 2018-04-05
RU2018104102A (ru) 2019-08-27
ES2891523T3 (es) 2022-01-28
MX2022014277A (es) 2022-12-07
EP3325080B1 (en) 2021-09-01
AU2022275397A1 (en) 2023-01-05
HUE056410T2 (hu) 2022-02-28
AU2016297823A1 (en) 2018-02-15
RU2018104102A3 (pl) 2019-11-06
AU2021200146A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
IL291932B1 (en) Nanoparticle preparations for prolonged treatment
PL3325080T3 (pl) Sposoby lepszego dostarczania środków czynnych do guzów
HK1252512A1 (zh) 向眼部遞送藥劑的方法
LT3386484T (lt) Gydomųjų medžiagų sudėtis ir pristatymo metodai
IL249837B (en) An inhaler for administering active substances through the lungs
HK1258062A1 (zh) 給予惡拉戈利的方法
SG10201913124RA (en) Methods for enhancing efficacy of therapeutic immune cells
IL250677B (en) Cancer treatment using anti-nkg2a agents
ZA201506916B (en) Microstructure array for delivery of active agents
IL247722A0 (en) Pharmaceutical preparations containing active medicinal compounds for the treatment of hematological cancers
IL247721A0 (en) Pharmaceutical preparations containing active medicinal compounds for the treatment of solid tumors
HK1245834A1 (zh) 一種b細胞用於體內遞送治療劑
IL249455A0 (en) Complexes of mineral-amino acids with active substances
PL3325081T3 (pl) Sposoby dostarczania limfatycznego środków czynnych
PL3021839T3 (pl) Kompozycje do leczenia zwłóknienia
IL253461A0 (en) Hydrogels for the release of therapeutic compounds
ZA201700518B (en) Use of active compound compositions
EP3313380A4 (en) COMPOSITION FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO AN ANIMAL
EP3094347A4 (en) Methods for enhancing the delivery of active agents
PT3142641T (pt) Formulações para o tratamento de hipertiroidismo
SG11201700059WA (en) Therapeutic agent for keratoconjunctive disorder
IL240710A0 (en) Administration of sdf-1 to treat ischemic tissue
AU2013901241A0 (en) Composition for controlled delivery of therapeutic agents